EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Glioblastoma microenvironment—from biology to therapy

Renee D Read iD, Zoe M Tapp, Prajwal Rajappa, Dolores Hambardzumyan iD

Genes & Development · 29.05.2024

DOI: 10.1101/gad.351427.123 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Genes & Development, online erschienen am 29.05.2024. Verfasst von Renee D Read und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, Georgia 30322, USA; dolores.hambardzumyan@mssm.edu ren…. Hauptthemen laut MEDLINE: Tumor Microenvironment, Glioblastoma, Brain Neoplasms. Die Arbeit wurde bisher 36-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, National Institutes of Health, National Institute of Neurological Disorders and Stroke.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma (GBM) is the most aggressive primary brain cancer. These tumors exhibit high intertumoral and intratumoral heterogeneity in neoplastic and nonneoplastic compartments, low lymphocyte infiltration, and high abundance of myeloid subsets that together create a highly protumorigenic immunosuppressive microenvironment. Moreover, heterogeneous GBM cells infiltrate adjacent brain tissue, remodeling the neural microenvironment to foster tumor electrochemical coupling with neurons and metabolic coupling with nonneoplastic astrocytes, thereby driving growth. Here, we review heterogeneity in the GBM microenvironment and its role in low-to-high-grade glioma transition, concluding with a discussion of the challenges of therapeutically targeting the tumor microenvironment and outlining future research opportunities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentGlioblastomaBrain NeoplasmsHumansAnimals

Stichwörter der Autor:innen

glial cellsglioblastomaglioma stem celllymphoid cellsmyeloid cellsstem cell nichetumor microenvironment

Autor:innen und Institutionen

  • Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, Georgia 30322, USA; dolores.hambardzumyan@mssm.edu renee.read@emory.edu prajwal.rajappa@nationwidechildrens.org.
  • Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia 30322, USA.
  • Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia 30322, USA.
  • The Steve and Cindy Rasmussen Institute for Genomic Medicine, Nationwide Children's Hospital, Columbus, Ohio 43205, USA.
  • The Steve and Cindy Rasmussen Institute for Genomic Medicine, Nationwide Children's Hospital, Columbus, Ohio 43205, USA; dolores.hambardzumyan@mssm.edu renee.read@emory.edu prajwal.rajappa@nationwidechildrens.org.
  • Department of Pediatrics, The Ohio State University Wexner Medical Center, Columbus, Ohio 43215, USA.

ORCID-Profile: Renee D Read, Dolores Hambardzumyan

Förderung

  • NINDS NIH HHS
  • National Institutes of Health
  • National Institute of Neurological Disorders and Stroke
  • NIH/NINDS
  • Ian's Friends Foundation
  • Ohio Cancer Research

Zitieren

APA

Read, R. D., Tapp, Z. M., Rajappa, P., & Hambardzumyan, D. (2024). Glioblastoma microenvironment—from biology to therapy. Genes & Development. https://doi.org/10.1101/gad.351427.123

Vancouver

Read RD, Tapp ZM, Rajappa P, Hambardzumyan D. Glioblastoma microenvironment—from biology to therapy. Genes & Development. 2024. doi:10.1101/gad.351427.123

BibTeX
@article{Read2024,
  author = {Read, Renee D and Tapp, Zoe M and Rajappa, Prajwal and Hambardzumyan, Dolores},
  title = {Glioblastoma microenvironment—from biology to therapy},
  journal = {Genes & Development},
  year = {2024},
  doi = {10.1101/gad.351427.123}
}
Kostenlos starten →